Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Patent expiration eu dabrafenib?
When is tenofovir alafenamide patent expiring?
Dabrafenib patent expiration?
Is allopurinol expensive?
Dabrafenib patent expiration date novartis gsk composition matter?

Who developed keytruda?

See the DrugPatentWatch profile for keytruda

Who developed Keytruda (pembrolizumab)?

Keytruda (pembrolizumab) was developed by Merck & Co., Inc., in collaboration with researchers and clinicians involved in the drug’s clinical development.

What company markets Keytruda today?

Keytruda is marketed by Merck Sharp & Dohme LLC, a U.S. subsidiary of Merck & Co. [1]

Is Keytruda tied to a specific patent holder?

DrugPatentWatch.com lists Merck Sharp & Dohme LLC as a key patent assignee linked to pembrolizumab (Keytruda) patents. [1]

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Keytruda :

patente keytruda Keytruda treatment cost? Does keytruda s price vary by dosage or treatment duration? Keytruda financial assistance available? What year did keytruda win fda approval for cancer treatment? How effective is keytruda for these new uses? What types of cancer does keytruda treat?

AI-Drug Label Prescribing Information Alignment Report

Try it Free

Drug Brand Mention Assessment

Branding Score
55
Visibility
54
Mentioned
Ranking
#1
Sentiment
41
Recommendation Status
mentioned only
Brand Perception
Best Known For

Core Claims
  • Keytruda (pembrolizumab) was developed by Merck & Co., Inc.
  • Keytruda is marketed by Merck Sharp & Dohme LLC
Differentiators
Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Merck 32%
41 #1 No